These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 31443274)

  • 1. Dry Eye Disease: A Review of Epidemiology in Taiwan, and its Clinical Treatment and Merits.
    Kuo YK; Lin IC; Chien LN; Lin TY; How YT; Chen KH; Dusting GJ; Tseng CL
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31443274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management Strategies for Evaporative Dry Eye Disease and Future Perspective.
    Rolando M; Merayo-Lloves J
    Curr Eye Res; 2022 Jun; 47(6):813-823. PubMed ID: 35521685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Dry Eye Disease (DED) in Asia: Strategies for Short Tear Film Breakup Time-Type DED.
    Kawahara A
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Management of Dry Eye Disease: Beyond Artificial Tears.
    Matossian C; Crowley M; Periman L; Sorkin S
    Clin Ophthalmol; 2022; 16():3911-3918. PubMed ID: 36452043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dry Eye Disease Associated with Meibomian Gland Dysfunction: Focus on Tear Film Characteristics and the Therapeutic Landscape.
    Sheppard JD; Nichols KK
    Ophthalmol Ther; 2023 Jun; 12(3):1397-1418. PubMed ID: 36856980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic, environmental and lifestyle risk factors for dry eye disease in a mediterranean caucasian population.
    García-Marqués JV; Talens-Estarelles C; García-Lázaro S; Wolffsohn JS; Cerviño A
    Cont Lens Anterior Eye; 2022 Oct; 45(5):101539. PubMed ID: 34789408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Review of the Clinical Trials Conducted for Dry Eye Disease and the Impact of the Vehicle Comparators in These Trials.
    Nichols KK; Evans DG; Karpecki PM
    Curr Eye Res; 2021 May; 46(5):609-614. PubMed ID: 33238774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
    Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
    Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress of nanomedicine in managing dry eye disease.
    Lv Z; Li S; Zeng G; Yao K; Han H
    Adv Ophthalmol Pract Res; 2024; 4(1):23-31. PubMed ID: 38356795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study design and baseline findings from the progression of ocular findings (PROOF) natural history study of dry eye.
    McDonnell PJ; Pflugfelder SC; Stern ME; Hardten DR; Conway T; Villanueva L; Hollander DA
    BMC Ophthalmol; 2017 Dec; 17(1):265. PubMed ID: 29284427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial.
    Zhang X; Zhang B; Peng S; Zhang G; Ma J; Zhu W
    Trials; 2022 Jul; 23(1):605. PubMed ID: 35897025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry Eye Disease: Present Challenges in the Management and Future Trends.
    Al-Saedi Z; Zimmerman A; Bachu RD; Dey S; Shah Z; Baugh R; Boddu SH
    Curr Pharm Des; 2016; 22(28):4470-90. PubMed ID: 27296759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of dry eye disease in the UK: The Aston dry eye study.
    Vidal-Rohr M; Craig JP; Davies LN; Wolffsohn JS
    Cont Lens Anterior Eye; 2023 Jun; 46(3):101837. PubMed ID: 37003925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry eye: why artificial tears are not always the answer.
    Kim M; Lee Y; Mehra D; Sabater AL; Galor A
    BMJ Open Ophthalmol; 2021; 6(1):e000697. PubMed ID: 33907713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease.
    Fjaervoll K; Fjaervoll H; Magno M; Nøland ST; Dartt DA; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Dec; 100(8):861-877. PubMed ID: 35441459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Conditions Associated with Severity of Dry Eye Signs and Symptoms in the Dry Eye Assessment and Management Study.
    Yu K; Bunya V; Maguire M; Asbell P; Ying GS;
    Ophthalmology; 2021 Oct; 128(10):1384-1392. PubMed ID: 33785415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.